(Q37779306)

23 August 2017

1 reference

title

Personalized medicine in oncology: tailoring the right drug to the right patient (English)

1 reference

23 August 2017

1 reference

personalized medicine

1 reference

Yuqiu Jiang

1

1 reference

PubMed ID

20701441

23 August 2017

Mu Wang

series ordinal

2

1 reference

23 August 2017

1 August 2010

1 reference

23 August 2017

Biomarkers in Medicine

1 reference

23 August 2017

4

1 reference

23 August 2017

4

1 reference

23 August 2017

523-533

1 reference

Personalized medicine: individualized care of cancer patients

23 August 2017

1 reference

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

21 January 2018

1 reference

Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy

21 January 2018

1 reference

On the eve of personalized medicine in oncology

21 January 2018

1 reference

Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment

21 January 2018

1 reference

Personalized medicine and proteomics: lessons from non-small cell lung cancer

21 January 2018

1 reference

Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab.

21 January 2018

1 reference

The genomic landscapes of human breast and colorectal cancers

21 January 2018

1 reference

Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.

21 January 2018

1 reference

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

Genes associated with breast cancer metastatic to bone

21 January 2018

1 reference

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

21 January 2018

1 reference

Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer

21 January 2018

1 reference

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer

21 January 2018

1 reference

A 2-gene classifier for predicting response to the farnesyltransferase inhibitor tipifarnib in acute myeloid leukemia

21 January 2018

1 reference

Proteomics research to discover markers: what can we learn from Netflix?

21 January 2018

1 reference

Proteomics by mass spectrometry: approaches, advances, and applications

21 January 2018

1 reference

Pathology of the future: molecular profiling for targeted therapy

21 January 2018

1 reference

Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.

21 January 2018

1 reference

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

Tissue microarrays for predictive molecular pathology

21 January 2018

1 reference

Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays

21 January 2018

1 reference

Comparative multi-methodological measurement of ERBB2 status in breast cancer

21 January 2018

1 reference

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

21 January 2018

1 reference

Methods and applications of antibody microarrays in cancer research

21 January 2018

1 reference

Multiplexed sandwich assays in microarray format

21 January 2018

1 reference

21 January 2018

Protein chip technology

1 reference

Antibody arrays for high-throughput screening of antibody-antigen interactions

21 January 2018

1 reference

Proteomic profiling of the cancer microenvironment by antibody arrays

21 January 2018

1 reference

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

Proteomic contributions to personalized cancer care.

21 January 2018

1 reference

A molecular imaging paradigm to rapidly profile response to angiogenesis-directed therapy in small animals

21 January 2018

1 reference

Molecular imaging of breast cancer.

21 January 2018

1 reference

Use of new imaging techniques to predict tumour response to therapy

21 January 2018

1 reference

Molecular imaging of cancer with positron emission tomography

21 January 2018

1 reference

Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.

21 January 2018

1 reference

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

21 January 2018

1 reference

Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology

21 January 2018

1 reference

Therapeutic targeting of EGFR in malignant gliomas

21 January 2018

1 reference

Hsp90 as a therapeutic target in patients with oesophageal carcinoma

21 January 2018

1 reference

Novel targeted drug therapies for the treatment of childhood acute leukemia

21 January 2018

1 reference

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review

21 January 2018

1 reference

Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer

21 January 2018

1 reference

Imatinib and beyond--exploring the full potential of targeted therapy for CML.

21 January 2018

1 reference

Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)-based mutagenesis screen: high efficacy of drug combinations

21 January 2018

1 reference

Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

21 January 2018

1 reference

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

21 January 2018

1 reference

PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies

21 January 2018

1 reference

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

21 January 2018

1 reference

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications

21 January 2018

1 reference

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.

21 January 2018

1 reference

Irinotecan (CPT-11): pharmacology and clinical applications

21 January 2018

1 reference

Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

21 January 2018

1 reference

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.

21 January 2018

1 reference

Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients

21 January 2018

1 reference

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

21 January 2018

1 reference

Balancing life-style and genomics research for disease prevention

21 January 2018

1 reference

Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics

21 January 2018

1 reference

Clinical assessment incorporating a personal genome

21 January 2018

1 reference

The complete genome of an individual by massively parallel DNA sequencing

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.10.66

1 reference

23 August 2017

1 reference

PubMed ID

20701441